TrialAntimicrobial agents and chemotherapy2015

Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine.

Daniel S Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.